Related Experiment Videos
Human laminin produces human platelet aggregation in vitro
R N Willette1, B L Storer, R K Clark
1Department of Pharmacology, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406-0939.
Life Sciences
|January 1, 1994
Summary
Human laminin triggers platelet aggregation in a subset of individuals, involving thromboxane and the VLA-6 receptor. This suggests laminin
Area of Science:
- Biochemistry
- Hematology
- Cell Biology
Background:
- Laminins are crucial extracellular matrix proteins.
- Platelet aggregation is vital for hemostasis and thrombosis.
Purpose of the Study:
- To investigate the effects of laminin isoforms on human platelet aggregation.
- To characterize the mechanisms underlying laminin-induced platelet activation.
Main Methods:
- Platelet-rich plasma from 26 healthy volunteers was used.
- Platelet aggregation was measured in response to different laminin isoforms.
- Specific antagonists and antibodies were employed to elucidate the signaling pathways.
Main Results:
- Human laminin induced a biphasic platelet aggregation response in 38% of individuals.
- This response was concentration-dependent and mediated by the VLA-6 receptor.
- The secondary phase was thromboxane-dependent and blocked by GPIIb/IIIa antagonists.
Conclusions:
- Human laminin can induce platelet aggregation in a significant portion of the population.
- The VLA-6 (alpha 6 beta 1) integrin is essential for this interaction.
- Laminin may play a role in hemostasis and thrombogenesis in certain individuals.